← Open Payments lookup

RACHEL ROWLAND: Open Payments

NPI 1548403454 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,034 in 21 payments from 8 companies in 2025. Trend: 2023 $1,942 · 2024 $1,300 · 2025 $1,034

Food & beverage: $1,034
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.2$239
Gilead Sciences, Inc.7$220
ViiV Healthcare Company6$149
Otsuka America Pharmaceutical, Inc.1$124
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$112
ABBVIE INC.1$111
Merck Sharp & Dohme LLC2$44
EMD Serono, Inc.1$35

Products named: JARDIANCE, REXULTI, CABENUVA, XIFAXAN, VRAYLAR, Biktarvy, PIFELTRO, DOVATO.

Industry payments across LA — which companies pay providers there.